B. Timothy Walsh, M.D.
Name, Degree: B. Timothy Walsh, M.D.
Role(s) in Work Group: Chair, Eating Disorders Work Group
Institutional Affiliation(s): College of Physicians & Surgeons, Columbia University; New York State Psychiatric Institute
City, State: New York, NY
Biographical Sketch:
Dr. Walsh, a graduate of Princeton University and Harvard Medical School, joined the staff of Columbia University Medical Center in 1979 and established the Eating Disorders Research Unit at New York State Psychiatric Institute. Dr. Walsh is currently the Ruane Professor of Pediatric Psychopharmacology in the Department of Psychiatry at the College of Physicians and Surgeons, Columbia University, and Director, Division of Clinical Therapeutics, New York State Psychiatric Institute.
Dr. Walsh’s research group has examined biological and psychological abnormalities that contribute to the development and perpetuation of disturbances in eating behavior, and investigated both psychological and pharmacological treatments for anorexia nervosa, bulimia nervosa, and binge eating disorder. He was a member of the DSM-IV Task Force and chaired the Eating Disorders Workgroup for DSM-IV. He is a past president of the Academy for Eating Disorders and is currently President-Elect of the Eating Disorders Research Society.
Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V : Three calendar years before nomination and Each year thereafter through the present calendar year. (For 2008, activities to date and commitments for remainder of year.)
|
Non-Profit and Advocacy Organizations |
Year(s) |
Role |
|
Eating Disorders Research Society |
2007-2008 |
President Elect |
The two tables below represent Dr. Walsh’s disclosure of significant interests and affiliations for: (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.
Dr. Walsh has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.
|
KEY NUMBER:
1. Consultation Fees (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options |
6. Expert testimony
7. Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10. Other (specify) |
Disclosure of significant interests including: Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
Ortho-McNeil Pharmaceuticals |
2003 - 2005 |
3 |
|
Glaxo-Smith-Kline |
2005 |
3 |
|
Eli Lilly & Company |
2000 - 2005 |
3 |
|
Abbott Laboratories |
2005 - 2007 |
3 |
|
Academy for Eating Disorders (Assoc Editor, Int J Eat Dis) |
2003 - 2006 |
4 |
|
Gurze Books |
2003 - 2006 |
4 |
|
American Psychiatric Association (for lecture supported by Ortho-McNeil Pharmaceuticals) |
2003 - 2004 |
4 |
|
Health Learning Systems (for lecture supported by Ortho-McNeil Pharmaceuticals) |
2004 |
4 |
|
Complete Health Care Communications (for consultation to an investigator-initiated study supported by Ortho-McNeil Pharmaceuticals) |
2004 |
1 |
|
Guilford Press |
2005 |
4 |
Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
Academy for Eating Disorders (Assoc Editor, Int J Eat Dis) |
2007 - 2008 |
4 |
|
Gurze Books |
2007 |
4 |
|
British Medical Journal |
2007 |
4 |
| AstraZeneca, "The Quantification of Ingestive Behavior" Investigator-initiated project, part of the "Columbia University-AstraZeneca collaboration regarding diabetes, obesity, atherosclerosis and dyslipidemia" |
2008 - 2009 |
3 (Co-Investigator) |